<DOC>
	<DOCNO>NCT01604590</DOCNO>
	<brief_summary>This study subject diagnosis brain tumor call glioblastoma treat bevacizumab . This study use new MRI technique compare image blood vessel tumor structure effectiveness bevacizumab .</brief_summary>
	<brief_title>Imaging Biomarkers Tissue Microstructure Vasculature Predictors Glioblastoma Multiforme</brief_title>
	<detailed_description>This study subject diagnosis brain tumor call glioblastoma treat bevacizumab . Bevacizumab drug doctor believe best treatment option available subject time type tumor . Bevacizumab affect growth blood vessel tumor glioblastoma , thus effectively starve tumor oxygen food . Magnetic Resonance Imaging ( MRI ) test do machine radiology department take picture body use special magnet , rather X-rays . With new MRI scan technique investigator take , detailed image vessel tumor structure . This project allow u compare image vessel tumor structure effectiveness Bevacizumab treatment option . With project investigator hopefully develop accurate way predict whether Bevacizumab effective treatment option patient .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Age 18 80 year age Progressive glioblastoma patient plan receive bevacizumab Karnofsky Performance Status 50 ( vd . Appendix A ) Established pathologic diagnosis glioblastoma Prior treatment radiation chemotherapy Neuroimaging progression glioblastoma Able willing provide inform consent ( consent guardian ) Contraindication MRI Contraindication bevacizumab therapy Concurrent enrollment neuroimaging trial Prior therapy bevacizumab Known hypersensitivity MRI contrast Females nursing pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Glioblastoma</keyword>
	<keyword>Imaging Biomarkers</keyword>
	<keyword>Bevacizumab</keyword>
	<keyword>MRI</keyword>
</DOC>